Pick Your Biotech Stocks Here

When Matt "B2B" Jacobs and I decided we had to learn the B2B world, everyone told us that we were too late, the move had occurred.

That was wrong. And our method of learning, a B2B rotisserie league, left us with hefty gains on paper and in real life.

Remember, the genesis for this project came from our own experiences with rotisserie leagues: They force you to get involved. I learned that from John Walsh, when he was editor of Inside Sports Magazine.

Walsh drafted me into one of the leagues that he had created because he wanted everybody at Inside Sports to be savvy about players. (I was writing at American Lawyer at the time but I loved sports and was anxious to be involved.)

So, with that in mind I asked Melissa "Genome" Kasper, another research analyst at my firm, to put together a list of draft candidates for a biotech rotisserie league, an area that I admit to being in need of a brush-up.

The idea is the same at the B2B draft: We will read all of your comments about each one of these names in our boards and we will draft with a mythical $1 million each next Monday. So you have five days to weigh in.

Like last time, we expect to rely heavily on your comments, which were incredibly helpful when we drafted the B2Bers.

So, without further adieu, here are the 20:

Biotech Draft Board
Amgen (AMGN Quote)	Genentech (DNA Quote)
Immunex (IMNX Quote)	Biogen (BGEN Quote)
MedImmune (MEDI Quote)	Affymetrix (AFFX Quote)
Celera Genomics (CRA Quote)	Human Genome Sciences (HGSI Quote)
Millennium Pharmaceuticals (MLNM Quote)	Incyte Pharmaceuticals (INCY Quote)
Abgenix (ABGX Quote)	Inhale Therapeutic Systems (INHL Quote)
Alkermes (ALKS Quote)	IDEC Pharmaceuticals (IDPH Quote)
CuraGen (CRGN Quote)	Genyzme (GENZ Quote)
Vertex Pharmaceuticals (VRTX Quote)	Protein Design Labs (PDLI Quote)
Imclone Systems (IMCL Quote)	Transkaryotic Therapies (TKTX Quote)

Once these entries are posted on the ticker-board section of our message boards, I am going to ask Genome Kasper to put her squibs of description under each entry.